Ankylosing spondylitis epidemiology and demographics
|
Ankylosing spondylitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ankylosing spondylitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Ankylosing spondylitis epidemiology and demographics |
|
Ankylosing spondylitis epidemiology and demographics in the news |
|
Blogs on Ankylosing spondylitis epidemiology and demographics |
|
Risk calculators and risk factors for Ankylosing spondylitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prevalence of axial spondyloarthritis (axSpA) or ankylosing spondylitis in a population depends upon the following 1)Ethnic groups 2)Selection of subjects for evaluation and 3)The criteria for diagnosis.It shows a clear evidence that correlation between the prevalence of ankylosing spondylitis (AS)/axial spondyloarthritis (axSpA) in a given population and the prevalence of human leukocyte antigen (HLA)-B27 exits.
Epidemiology and Demographics
Prevalence[1]
- The incidence of ankylosing spondylitis is approximately 7-490 per 100,000 individuals worldwide.
- In the year 2009, according to National Health and Nutrition Examination Survey (NHANES) the incidence of ankylosing spondylitis was estimated to be 6.1% cases per 100,000 individuals worldwide.
Incidence[2]
- The incidence of fractures in ankylosing spondylitis is approximately 4 to 18 percent .
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
References
- ↑ Reveille JD, Weisman MH (June 2013). "The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States". Am. J. Med. Sci. 345 (6): 431–6. PMC 4122314. PMID 23841117.
- ↑ Mundwiler ML, Siddique K, Dym JM, Perri B, Johnson JP, Weisman MH (2008). "Complications of the spine in ankylosing spondylitis with a focus on deformity correction". Neurosurg Focus. 24 (1): E6. doi:10.3171/FOC/2008/24/1/E6. PMID 18290744.